CN1048164C - Compound chinaroot greenbrier oral liquid - Google Patents
Compound chinaroot greenbrier oral liquid Download PDFInfo
- Publication number
- CN1048164C CN1048164C CN 93111668 CN93111668A CN1048164C CN 1048164 C CN1048164 C CN 1048164C CN 93111668 CN93111668 CN 93111668 CN 93111668 A CN93111668 A CN 93111668A CN 1048164 C CN1048164 C CN 1048164C
- Authority
- CN
- China
- Prior art keywords
- oral liquid
- add
- rhizoma smilacis
- raw materials
- smilacis chinensis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 20
- 150000001875 compounds Chemical class 0.000 title claims abstract description 10
- 244000261559 Smilax china Species 0.000 title abstract description 4
- 235000000485 Smilax china Nutrition 0.000 title abstract description 4
- 240000009022 Smilax rotundifolia Species 0.000 title abstract description 4
- 235000003205 Smilax rotundifolia Nutrition 0.000 title abstract description 4
- -1 al Species 0.000 title abstract description 4
- 239000002994 raw material Substances 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 241000353200 Microcanthus strigatus Species 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 7
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 210000002816 gill Anatomy 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 17
- 201000010099 disease Diseases 0.000 abstract description 16
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 16
- 206010018612 Gonorrhoea Diseases 0.000 abstract description 5
- 208000001786 gonorrhea Diseases 0.000 abstract description 5
- 206010052428 Wound Diseases 0.000 abstract description 4
- 208000027418 Wounds and injury Diseases 0.000 abstract description 4
- 241000251468 Actinopterygii Species 0.000 abstract description 3
- 206010006187 Breast cancer Diseases 0.000 abstract description 3
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 3
- 206010030155 Oesophageal carcinoma Diseases 0.000 abstract description 3
- 208000015634 Rectal Neoplasms Diseases 0.000 abstract description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract description 3
- 206010017758 gastric cancer Diseases 0.000 abstract description 3
- 206010038038 rectal cancer Diseases 0.000 abstract description 3
- 201000001275 rectum cancer Diseases 0.000 abstract description 3
- 201000011549 stomach cancer Diseases 0.000 abstract description 3
- 240000000233 Melia azedarach Species 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 208000000461 Esophageal Neoplasms Diseases 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 235000017784 Mespilus germanica Nutrition 0.000 abstract 1
- 244000182216 Mimusops elengi Species 0.000 abstract 1
- 235000000560 Mimusops elengi Nutrition 0.000 abstract 1
- 240000000377 Tussilago farfara Species 0.000 abstract 1
- 235000004869 Tussilago farfara Nutrition 0.000 abstract 1
- 235000007837 Vangueria infausta Nutrition 0.000 abstract 1
- 201000004101 esophageal cancer Diseases 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000002980 postoperative effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 238000003745 diagnosis Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000003014 reinforcing effect Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 201000008275 breast carcinoma Diseases 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 208000007451 chronic bronchitis Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 2
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 201000005619 esophageal carcinoma Diseases 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DYUUPIKEWLHQGQ-KYHIUUMWSA-N (3S, 5R, 6S, 3'R, 6'R)-5,6-epoxy-5,6-dihydro- beta,epsilon-carotene-3,3'-diol Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC3C(=CC(O)CC3(C)C)C DYUUPIKEWLHQGQ-KYHIUUMWSA-N 0.000 description 1
- BNHIQKVOPNHQKO-ZPWDLUOLSA-N (3s,4ar,6ar,6ar,6br,8s,8as,12s,12as,14ar,14br)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,6a,7,8,9,12,12a,13,14,14a-tetradecahydro-1h-picene-3,8-diol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@@H]2[C@@H]3[C@H](C)C(C)=CC[C@]3(C)[C@@H](O)C[C@]21C BNHIQKVOPNHQKO-ZPWDLUOLSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 206010002176 Anal stenosis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000722917 Cacosmia Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241001597062 Channa argus Species 0.000 description 1
- QBDCOUHKEVYWLO-UHFFFAOYSA-N Decanoyl acetaldehyde Chemical compound CCCCCCCCCC(=O)CC=O QBDCOUHKEVYWLO-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- CNKHWTIOFSWRHP-UHFFFAOYSA-N Faradiol Natural products CC1C2C3CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CC(O)C2(C)C(=C)C=C1C CNKHWTIOFSWRHP-UHFFFAOYSA-N 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- DYUUPIKEWLHQGQ-UWYDEOQVSA-N Lutein 5,6-epoxide Natural products O[C@H]1C=C(C)[C@H](/C=C/C(=C\C=C\C(=C/C=C/C=C(\C=C\C=C(/C=C/[C@]23C(C)(C)C[C@H](O)C[C@@]2(C)O3)\C)/C)\C)/C)C(C)(C)C1 DYUUPIKEWLHQGQ-UWYDEOQVSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001502129 Mullus Species 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 208000012898 Olfaction disease Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229930195392 azedarachin Natural products 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 208000021735 chronic enteritis Diseases 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical group CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 150000008195 galaktosides Chemical class 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- DYUUPIKEWLHQGQ-FJOIUHRLSA-N lutein 5,6-epoxide Chemical compound C(/[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C DYUUPIKEWLHQGQ-FJOIUHRLSA-N 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000019546 parosmia Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 210000004915 pus Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- BIVIKXQHDMPIQD-MRXMRZKZSA-N taraxanthin Natural products C[C@H]1CC(C)(C)[C@@]2(O[C@]2(C)C1)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=C[C@H]3C(=C[C@H](O)CC3(C)C)C)C)C BIVIKXQHDMPIQD-MRXMRZKZSA-N 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The main raw materials of the oral liquid are firewood fish and chinaroot greenbrier, and are matched with houttuynia, coltsfoot flower, medlar, sun euphorbia herb and szechwan chinaberry fruit, the weight percentages of the raw materials are 22-25: 14-25: 20-28: 5-10: 12-15: 1-4, and 1153 clinical tests show that the compound chinaroot greenbrier oral liquid has high cure rate on rheumatoid diseases, gonorrhea and wounds after operations, has obvious curative effects on rectal cancer, gastric cancer, esophageal cancer, breast cancer and the like, and is convenient to take and free of any side effect.
Description
Compound recipe Rhizoma Smilacis Chinensis oral liquid belongs to a kind of health product by the Chinese medicine preparation.
The domestic market oral liquid is of a great variety, and its effect is each has something to recommend him with effect, and major part belongs to auxotype.
Microcanthus strigatus is the spleen reinforcing had a preference for of people, the health product of diuretic, be the important paramedicines of postoperative patient, but inconvenient eating is subjected to the source of goods and the restriction in season on the market again.
Therefore develop a kind of postoperative wound healing, softening hardness and disperse swelling of helping, some disease is still had certain curative effect, and the health oral liquid of taking convenience then is a purpose of the present invention.
Technical scheme of the present invention is: it is Microcanthus strigatus, Rhizoma Smilacis Chinensis that the primary raw material of compound recipe Rhizoma Smilacis Chinensis oral liquid is formed, and is equipped with Herba Houttuyniae, Flos Farfarae, Fructus Lycii, Herba Euphorbiae Helioscopiae and Fructus Toosendan.Microcanthus strigatus cuts open tripe and gills clean, other raw materials are cleaned after the roguing one too and are incorporated container into and add decocting in water and fry in shallow oil twice, add water inventory and be 4～5 times of raw material, decocting time is 30～45 minutes for the first time, be about 1 hour for the second time, merge boil for twice the liquid of boiling medicine through coarse filtration, be concentrated into and add about 10% of water inventory and add an amount of sucrose again, cooling, bottled; Various proportion of raw materials are in the oral liquid: Microcanthus strigatus 22～25%, Rhizoma Smilacis Chinensis 14～25%, Herba Houttuyniae 20～28%, Flos Farfarae 5～10%, Fructus Lycii 12～15%, Herba Euphorbiae Helioscopiae 12～15%, Fructus Toosendan 1～4%.
Microcanthus strigatus is a popular name, the formal name used at school Ophicephalus argus, and different name has snakeheaded fish, mullet, black match end fish etc.Nature and flavor are sweet, cold; The effect of tool spleen reinforcing, kidney tonifying profit gold, diuretic; Cure mainly diseases such as edema, arthralgia chiefly caused by damp pathogen, beriberi, hemorrhoid, scabies; The edible portion of 100 grams contains protein 19.8g, fatty 1.4g, and calcium 57mg, phosphorus 163g, ferrum 0.5mg, thiamine 0.03mg, riboflavin 0.25mg, nicotinic acid 2.8mg, muscle contain 18 kinds of free amino acids such as histidine, citrulline, proline, serine.
Rhizoma Smilacis Chinensis has another name called China root greenbrier rhizome, Rhizoma Smilacis Chinensis, Hepar Gallus domesticus root, roadside brush etc.Nature and flavor are sweet, warm; The effect of tool wind-damp dispelling, diuresis, detumescence poison; Cure mainly arthralgia, muscle numbness, have loose bowels, disease such as dysentery, edema, gonorrhea, furuncle, toxic swelling, scrofula, hemorrhoid.The Rhizoma Smilacis Chinensis rhizome contains diosgenin and the multiple Saponin that is made of diosgenin, contains alkaloid, phenols, aminoacid, organic acid and saccharide again.
Herba Houttuyniae has another name called smelly pig nest, Herba Houttuyniae, Rhizoma Rohdeae Japonicae, Canis familiaris L. subsides ear.The effect of tool heat-clearing and toxic substances removing, inducing diuresis to remove edema.Cure mainly diseases such as pneumonia, pulmonary abscess, hematodiarrhoea, edema, gonorrhea, leucorrhea are many, carbuncle, eczema, scabies.Contain compositions such as volatile oil, houttuynine sodium bisulfite, cordarine, Quercetin, quercitrin, Isoquercitrin, auspicious all glycosides, hyperin, potassium chloride, potassium sulfate.
Flos Farfarae has another name called Flos Farfarae, snuff, Ai Donghua, 99 flowers are spent, seen to money.The effect of tool nourishing the lung to keep the adverse QI downward, preventing phlegm from forming and stopping coughing; Cure mainly diseases such as cough with dyspnea is panted, sore throat.Contain sterols such as faradiol, compositions such as globulariacitrin, hyperin, triterpenoid saponin, tannin, volatile oil, taraxanthin, gallic acid and malic acid.
Fructus Lycii has another name called Gou Qizi, dark purple green pepper, red bob ear, blood Fructus Lycii.Tool nourishing kidney, lung moistening, tonifying liver, the effect that makes eye bright.Cure mainly hepatic and renal YIN deficiency, soreness of the waist and knees, dizziness, dizzy, the many tears of blurred vision, cough due to consumptive disease, quench one's thirst, disease such as seminal emission.Contain carotene 3.39mg in 100 grams, thiamine 0.23mg, riboflavin 0.33mg, and compositions such as Yan acid, ascorbic acid, linoleic acid.
Herba Euphorbiae Helioscopiae has another name called Herba Polygoni nepalensis, beautiful phoenix Ganoderma, Herba Euphorbiae Helioscopiae, sunshade grass.The effect of the capable water expectorant of tool, parasite killing, detoxifcation.Cure mainly edematous asthma, phlegm retention, breath with cough, disease such as bacillary dysentery, scrofula, tuberculosis fistula, bone marrow class.Contain compositions such as Quercetin, galactoside, Herba Euphorbiae Helioscopiae Saponin, triterpene, butanoic acid, Helioscopiol, dihydrofucosterol, glucose, fruit acid and maltose.
Fructus Toosendan has another name called chinaberry reality, Fructus Toosendan, core Fructus Jujubae, Fructus Toosendan, contains Azedarachin.The effect that tool removes is damp and hot, liver heat removing is scorching, end hypochondriac pain, parasite killing.Cure mainly cold limbs due to intense heat in the interior, pained, hypochondriac pain.
Behind above-mentioned raw materials science compatibility, adding 4 times of left and right sides decoctings boils twice, amount of water accounts for 3/5 for the first time, boiling the time of frying in shallow oil is 40 minutes, for the second time amount of water is 2/5, and decocting time is 1 hour, merge the decoction liquor after-filtration, be concentrated into amount of water 10% after add that suitable amount of sucrose contains cooling, packing gets final product, when taking three times on the one, taking medicine before meal is used.
Compound recipe Rhizoma Smilacis Chinensis oral liquid have promote the production of body fluid nourish blood, the effect of enriching yin and nourishing kidney, tonifying the lung spleen reinforcing, wind and heat dispersing.The modern medicine pharmacology proves, this oral liquid not only can tonifying liver blood, kidney tonifying essence, spleen invigorating profit gold to be to help the source of vital function, and can improve erythrocyte sum and hemoglobin, strengthen the human immunologic function with this, thereby reach appetite stimulator, the purpose of esophagus that the acceleration postoperative wound heals, mediation is narrow and intestinal, softening hardness and disperse swelling.Since 86 years, compound recipe Rhizoma Smilacis Chinensis oral liquid is used for clinical treating disease 1153 examples, wherein rheumatoid 113 examples, gonorrhea 187 examples, traumatic infection 34 examples, postoperative wound is 218 examples more, dysentery 54 examples, coronary heart disease 28 examples, insomnia's 127 examples, chronic bronchitis 152 examples, rectal cancer 31 examples, gastric cancer 38 examples, esophageal carcinoma 32 examples, breast carcinoma 37 examples, pulmonary carcinoma 59 examples, cervical cancer 43 examples have all obtained satisfied curative effect.(seeing the following form)
Typical case's case history:
Tan * *, man 54 years old, teacher, patient just time increase and accompany pus and blood, mucus oneself more than 10 month; Once certain hospital diagnosis was that " chronic enteritis " May of being in hospital is surplus, but all disease opinions are clearly better, and the anthelion gradually increases the weight of, after go to * * tumour hospital's diagnosis and treatment, be diagnosed as intestinal cancer through pathological section, suggestion row wtdey (changing its course) operation suffers patient's refusal, in the time of please present technique applicant diagnosis and treatment, except that above-mentioned all diseases, also be associated with lower abdominal distention pain, stool every day 9～15 times, be flat, and cacosmia is unpleasant.
Look into: the chronic painful sickly complexion of patient, the body skeletonize is walked with difficulty, heart rate 98 minutes, rule is neat, does not hear and pathologic murmur, and the liver spleen is not laid one's hand on and lump, and the bilateral groin can be laid one's hand on and enlargement, and hands is pressed lymph node, and pain is obviously.Anus is looked into: outward appearance kc position is no abnormal, and the touch anal stenosis locates respectively to have a swollen thing to give birth to relatively at 3.9 on the tooth trace, and matter is hard, surface irregularity, and with mucus blood sample thing, flavor is stench on the fingerstall.
Through compound recipe Rhizoma Smilacis Chinensis oral liquid for oral administration, every day 90ml, day clothes three times, each 30ml serve on 30 days, all diseases alleviate, appetite increases, spirit takes a turn for the better.Behind clothes 60 days, then lower abdominal distention pain disappears, stool every day 2～3 times, and no pus and blood mucus, but podex has still the time and weigh down the sense of expanding, and takes medicine half a year again, all diseases disappear, stool every day 1～2 time, and shaping.Microscopic examination of rectum is not seen swollen thing projection, but that the affected part basilar part touches is still harder, and the tenderness sense is arranged slightly, behind clothes 18 months, conscious all recover normal, followed the tracks of and followed up a case by regular visits to 3 years, no abnormal symptom occurs.
The king * *, the man, 57 years old, symptom was diarrhoea, frequent micturition, long-term heating, insomnia, nervous cardiopalmus etc., jin surplus the weight loss ten, economize * * hospital diagnosis is a chronic colitis, treated nearly 1 year front and back, no positive effect.Through taking compound recipe Rhizoma Smilacis Chinensis oral liquid after 30 days, appetite takes a turn for the better, and sleep, cardio palmus shape obviously improve, and facial complexion is transferred to ruddy by black green grass or young crops, serve on three months after, all disease knowing are removed.
Compound recipe Rhizoma Smilacis Chinensis oral liquid medicine source is abundant, draws materials easily, takes the back instant effect, and short treating period is without any side effects, applied widely, is a kind of health product of worth Application and Development.
Embodiment:
Take by weighing Microcanthus strigatus 500g, Rhizoma Smilacis Chinensis 500g, Herba Houttuyniae 500g, Flos Farfarae 150g, Fructus Lycii 300g, Herba Euphorbiae Helioscopiae 300g, Fructus Toosendan 50g.All medicines are removed most foreign material, and Microcanthus strigatus gills, and adds water 5000ml and boils 40 minutes after-filtration, and medicinal residues add water 4000ml again and continue to boil 1 hour after-filtration, merge twice filtrate and be concentrated into 900ml, add sucrose 200g, the cooling packing, every 30ml, oral dose are every day three times, each 30ml.
| Name of disease | The example number | Recovery from illness | Produce effects | Effectively | Invalid | Amount to | ||
| The example number | Cure rate % | Effective percentage % | ||||||
| Rheumatoid | ??113 | ????76 | ???11.5 | ????8 | ??4.5 | ????108 | ????76 | ????95.5 |
| ????86 | ???13 | ????9 | ??5 | |||||
| Gonorrhea | ??187 | ????86.7 | ???8.5 | ????4.8 | ????187 | ????86.7 | ????100 | |
| ????162 | ???16 | ????9 | ||||||
| Traumatic infection | ??34 | ????100 | ????34 | ????100 | ||||
| ????34 | ||||||||
| Post-operative wound is not healed | ??218 | ????100 | ????218 | ????100 | ||||
| ????218 | ||||||||
| Dysentery | ??54 | ????68.5 | ??27.7 | ????3.8 | ????54 | ????68.5 | ????100 | |
| ????37 | ??15 | ????2 | ||||||
| Coronary heart disease | ??28 | ????39.2 | ??10.7 | ????21.4 | ??28.7 | ????20 | ????39.2 | ????71.3 |
| ????11 | ??3 | ????6 | ??8 | |||||
| The insomnia | ??127 | ????81.1 | ??11.8 | ????7.1 | ????127 | ????81.1 | ????100 | |
| ????103 | ??15 | ????9 | ||||||
| Chronic bronchitis | ??152 | ????71 | ??15.1 | ????8.6 | ??5.3 | ????144 | ????71 | ????94.7 |
| ????108 | ??23 | ????13 | ??8 | |||||
| Rectal cancer | ??31 | ??51.6 | ????48.4 | ????31 | ????100 | |||
| ??16 | ????15 | |||||||
| Gastric cancer | ??38 | ??47.4 | ????52.6 | ????38 | ????100 | |||
| ??18 | ????20 | |||||||
| Esophageal carcinoma | ??32 | ??53.1 | ????46.9 | ????32 | ????100 | |||
| ??17 | ????15 | |||||||
| Breast carcinoma | ??32 | ??35.1 | ????51.4 | ??13.5 | ????32 | ????86.5 | ||
| ??13 | ????19 | ??5 | ||||||
| Pulmonary carcinoma | ??59 | ??57.6 | ????42.4 | ????59 | ????100 | |||
| ??34 | ????25 | |||||||
| Cervical cancer | ??43 | ??18.6 | ????39.5 | ??41.9 | ????25 | ????58.1 | ||
| ??8 | ????17 | ??18 | ||||||
| Add up to | ??1153 | ????1109 | ????96.18 | |||||
Claims (1)
1. compound recipe Rhizoma Smilacis Chinensis oral liquid, the primary raw material composition that it is characterized in that this oral liquid is a Microcanthus strigatus, Rhizoma Smilacis Chinensis, and be equipped with Herba Houttuyniae, Flos Farfarae, Fructus Lycii, Herba Euphorbiae Helioscopiae and Fructus Toosendan, Microcanthus strigatus cuts open tripe and gills clean, other raw materials are also cleaned after the roguing one and are incorporated container into and add to boil and fry in shallow oil twice, add water inventory and be 4～5 times of raw material, boiling the time of frying in shallow oil is 30～45 minutes for the first time, be about 1 hour for the second time, merge twice and boil the liquid of boiling medicine through coarse filtration, be concentrated into and add about 10% of water inventory, add an amount of sucrose again, cooling, bottling, various proportion of raw materials are in the oral liquid:
Microcanthus strigatus 22～25%
Rhizoma Smilacis Chinensis 14～25%
Herba Houttuyniae 20～28%
Flos Farfarae 5～10%
Fructus Lycii 12～15%
Herba Euphorbiae Helioscopiae 12～15%
Fructus Toosendan 1.0～4.0%
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93111668 CN1048164C (en) | 1993-08-24 | 1993-08-24 | Compound chinaroot greenbrier oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 93111668 CN1048164C (en) | 1993-08-24 | 1993-08-24 | Compound chinaroot greenbrier oral liquid |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1105246A CN1105246A (en) | 1995-07-19 |
| CN1048164C true CN1048164C (en) | 2000-01-12 |
Family
ID=4989432
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 93111668 Expired - Fee Related CN1048164C (en) | 1993-08-24 | 1993-08-24 | Compound chinaroot greenbrier oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1048164C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066335C (en) * | 1996-02-14 | 2001-05-30 | 雅安三九药业有限公司 | Houttuynia injection and preparation method thereof |
| AUPO864097A0 (en) | 1997-08-19 | 1997-09-11 | Peplin Pty Ltd | Anti-cancer compounds |
| AUPQ801700A0 (en) | 2000-06-07 | 2000-06-29 | Peplin Research Pty Ltd | Enzyme and viral activation |
| AUPQ923100A0 (en) | 2000-08-07 | 2000-08-31 | Peplin Research Pty Ltd | Treatment of prostate cancer |
| WO2002041828A2 (en) * | 2000-11-17 | 2002-05-30 | Dajun Yang | Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon |
| EP1838330A4 (en) | 2004-12-13 | 2010-07-07 | Peplin Research Pty Ltd | Treatment of solid cancers |
-
1993
- 1993-08-24 CN CN 93111668 patent/CN1048164C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1105246A (en) | 1995-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101797326A (en) | Chinese materia medica preparation for treating borborygmus diarrhoea and preparation method thereof | |
| CN103768523A (en) | Chinese herbal medicine compound preparation for treating malignant tumors and preparation method of compound preparation | |
| CN103638250B (en) | One treats prosopoplegic Chinese medicine preparation and preparation method thereof | |
| CN1109554C (en) | Medicine for treating allergic purpura | |
| CN1048164C (en) | Compound chinaroot greenbrier oral liquid | |
| CN117599125A (en) | A Chinese medicinal composition for supplementing calcium and strengthening bones for treating osteoporosis, and its preparation method and application | |
| CN104771462A (en) | Traditional Chinese medicine for treating chronic bronchitis and preparation method thereof | |
| CN101342331B (en) | Traditional Chinese medicine for treating pulmonitis and upper respiratory tract infection | |
| CN106177651A (en) | A kind of infantile malnutrition medicine | |
| CN112717012A (en) | Weight-losing compound essential oil and preparation method and application thereof | |
| CN110448672A (en) | One kind is for treating hyperplasia of prostate, prostatitic preparation and preparation method thereof | |
| CN104784459A (en) | Traditional Chinese medicine preparation for treating dizziness caused by neurasthenia and preparation method thereof | |
| CN104623545A (en) | Drug for assisting fatty liver patients to lose weight and preparation method thereof | |
| CN103990023A (en) | Semen citri reticulatae sperm activating medicament and preparation method thereof | |
| CN103520644B (en) | Traditional Chinese medicine composition used for treating phlegm stagnation type hyperlipidaemia and preparation method of composition | |
| CN115252700B (en) | Traditional Chinese medicine composition and medicine for treating cervical tinnitus and preparation method thereof | |
| CN103623328B (en) | The Chinese medicine composition for the treatment of subhealth state | |
| CN102370906B (en) | Traditional Chinese medicinal combination with function of relieving asthenopia and preparation method thereof | |
| CN104706961A (en) | Traditional Chinese medicine agent capable of moistening lung and clearing away heart-fire for patients with insomnia and dreaminess and preparation method of traditional Chinese medicine agent | |
| CN1070073C (en) | Medicine for treating hypercoagulable blood and its preparing process | |
| CN105250903A (en) | Traditional Chinese medicine physiotherapeutic liquid for treating numbness of limbs and preparation method of traditional Chinese medicine physiotherapeutic liquid | |
| CN104689205A (en) | Traditional Chinese preparation for treating insomnia and dreamful sleep and preparation method thereof | |
| CN105194258A (en) | Traditional Chinese medicine composition for treating diseases caused by kidney essence deficiency and decoction method of traditional Chinese medicine composition | |
| CN104547999A (en) | Oil for postpartum sweating | |
| CN104587345A (en) | Traditional Chinese medicine preparation for treating alzheimer disease and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |